Whitney's blog

ALBUQUERQUE – May 22, 2024 – Lovelace Medical Center (LMC) has earned The Joint Commission’s Gold Seal of Approval® for Advanced Certification in Spine Surgery (ACSS) by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a healthcare organization’s commitment to providing safe and quality patient care.

ALBUQUERQUE, NM – May 15, 2024 – Lovelace Health System has named George Wiley, MBA, MHA, chief financial officer (CFO) of Lovelace Medical Center and Heart Hospital of New Mexico at Lovelace Medical Center, effective May 28.

ALBUQUERQUE – May 9, 2024 – Lovelace Women’s Hospital (LWH) has been gifted two waterless milk warmers, six hospital-grade breast pumps and six breast pump trolleys by Millennium Medical Group, through a grant given by Blue Cross and Blue Shield of New Mexico (BCBSNM). 

ROSWELL, May 1, 2024 — Lovelace Regional Hospital (LRH) received an “A” safety grade in the Spring 2024 Leapfrog Hospital Safety Grade report, a national distinction recognizing its achievements protecting patients from harm and error in the hospital. This is the seventh safety grade “A” in a row for LRH.

A Statement from Community Health Corporation and Lovelace Health System

ALBUQUERQUE, NM – April 25, 2024 – Community Hospital Corporation (CHC) and Lovelace Health System (Lovelace) are pleased to partner with the County of Valencia, New Mexico (Valencia County), to expand access to healthcare services through the development of a new state-of-the-art acute care hospital in Los Lunas, New Mexico.

ALBUQUERQUE, NM – April 22, 2024 – Lovelace Health System has named Joseph C. Brown, MHA, chief operating officer (COO) of Lovelace Medical Center and Heart Hospital of New Mexico at Lovelace Medical Center, effective May 6.

ALBUQUERQUE – April 15, 2024 – Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) today announced the completion of New Mexico’s first FARAPULSE ™ Pulsed Field Ablation, a new alternative to standard-of-care thermal ablation, for the treatment of atrial fibrillation (AFib). A non-thermal approach for the treatment of intermittent AFib, it is proven to be an effective treatment option for patients while minimizing risks associated with thermal ablation.

ALBUQUERQUE – April 5, 2024 –Lovelace Medical Center (LMC) completed its first right robotic pleural biopsy. The minimally invasive thoracic procedure was performed by Luis Cerda, M.D., cardiothoracic surgeon with the New Mexico Heart Institute/Lovelace Medical Group, using Intuitive’s Da Vinci Xi robotic system, which makes smaller incisions than the traditional open procedure, resulting in less postoperative pain, reduced infection risk and quicker recovery and hospital stay.

ALBUQUERQUE – January 8, 2024 – New Mexico Heart Institute/Lovelace Medical Group (NMHI) has enrolled the first patient in the world in the RECOVER IV randomized study comparing management strategies for patients with cardiogenic shock using the Impella CP®, an FDA-approved temporary heart pump, versus standard of care.

Troy Greer returns to Lovelace as David Schultz assumes enterprise leadership role